Olema Pharmaceuticals, Inc. OLMA Current liabilities
Current liabilities at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentLiabilities.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s current liabilities?
- Olema Pharmaceuticals, Inc. (OLMA) reported current liabilities of $1.3M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s current liabilities changed year-over-year?
- Olema Pharmaceuticals, Inc.'s current liabilities increased by 111.6% year-over-year, from -$11.25M to $1.3M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s current liabilities?
- Over 3 years (2022 to 2025), Olema Pharmaceuticals, Inc.'s current liabilities has grown at a 16.1% compound annual growth rate (CAGR), from $7.02M to $10.98M.